Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000107

Chairperson & CEO sold 9,500 shares at an average $530.42 ($5,038,971)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-27 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-27 Sale : show line 2 in the form 10b5-1 −680 $525.81 $357,552 333,263 I
2026-07-27 Sale : show line 3 in the form 10b5-1 −890 $527.14 $469,152 332,373 I
2026-07-27 Sale : show line 4 in the form 10b5-1 −650 $528.51 $343,530 331,723 I
2026-07-27 Sale : show line 5 in the form 10b5-1 −1,797 $529.75 $951,959 329,926 I
2026-07-27 Sale : show line 6 in the form 10b5-1 −1,121 $530.49 $594,675 328,805 I
2026-07-27 Sale : show line 7 in the form 10b5-1 −1,836 $531.65 $976,107 326,969 I
2026-07-27 Sale : show line 8 in the form 10b5-1 −1,529 $532.38 $814,004 325,440 I
2026-07-27 Sale : show line 9 in the form 10b5-1 −957 $533.53 $510,590 324,483 I
2026-07-27 Sale : show line 10 in the form 10b5-1 −40 $535.04 $21,402 324,443 I
Open-market sales · 9,500 sh · avg $530.42 · $5,038,971

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-27 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option −9,500 265,410 I
Loading xslF345X06/primarydocument.xml…